Morgan Stanley Maintains Underweight on Doximity, Raises Price Target to $33
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley has maintained an Underweight rating on Doximity (NYSE:DOCS) but raised its price target from $26 to $33.
October 30, 2024 | 5:30 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Morgan Stanley has kept an Underweight rating on Doximity but increased the price target from $26 to $33, indicating a slightly more positive outlook.
The Underweight rating suggests a cautious stance, but the raised price target indicates some positive expectations. This mixed signal may result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100